Navigation Links
Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
Date:2/5/2008

re

the product for clinical development and commercial supply. Endo has

primary responsibility for regulatory, pre-clinical and clinical

development, and for commercializing the product in North America.

Endo has named this compound EN 3294 and will provide periodic updates

on the progress of this program in the future.

About Alexza Pharmaceuticals, Inc.

Alexza Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. Alexza has six product candidates in development; AZ-004 (Staccato loxapine) for the treatment of acute agitation in schizophrenic and bipolar disorder patients, AZ-001 (Staccato prochlorperazine) for the acute treatment of migraine headaches, AZ-104 (Staccato loxapine) for the acute treatment of migraine headaches, AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder, AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain in cancer and non-cancer patients, and AZ-007 (Staccato zaleplon) for the treatment of insomnia. More information, including this and past press releases from Alexza is available online at http://www.alexza.com.

Safe Harbor Statement

Alexza's policy is to only provide guidance on product candidates and corporate goals for the future one to two fiscal quarters, and to provide, update or reconfirm its guidance only by issuing a press release or filing
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
7. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
8. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. Prolexys Pharmaceuticals Initiates Phase 1 Study
11. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014 New high priced hepatitis ... D by a projected $2.9 to $5.8 billion next ... firm Milliman released today by the Pharmaceutical Care Management ... could increase by as much as 8.6 percent in ... including Sovaldi and Olysio. The study finds ...
(Date:7/29/2014)... Colo. , July 29, 2014 New ... (MARC) which could allow physicians to see and assess ... hold promise, according to study authors who released their ... 11 th Annual Meeting in Colorado ... to advance the field of neurointervention, a specialty that ...
(Date:7/29/2014)... -- Numotion,s Board of Directors has announced that as of ... company,s new Chief Executive Officer. Swinford joins ... he worked primarily for GE Healthcare Services, running businesses ranging ... His most recent position was as President and CEO of ... to join Numotion," said Mike Swinford . "I look ...
Breaking Medicine Technology:New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2New Technology May Improve Visualization Of The Brain During Stroke Treatment 2New Technology May Improve Visualization Of The Brain During Stroke Treatment 3Numotion Names Mike Swinford CEO 2
(Date:7/30/2014)... adults is being financially exploited often by their ... affects poor and black people. It merits the scrutiny ... cares about the dignity and well-being of older Americans, ... in the US. She led one of the largest ... which appear in the Journal of General Internal ...
(Date:7/30/2014)... accurate tests could be created to diagnose diseases such ... leading to earlier intervention, according to new findings from ... investigating the components of memory using a combination of ... used to create a diagnostic tool for distinguishing between ... forms of amnesia caused by head trauma. , ...
(Date:7/30/2014)... 2014 The global market for catheters ... according to a new study by Grand View Research, ... growing prevalence of diabetes, obesity and cardiovascular diseases is ... In addition, the introduction of technologically advanced catheters with ... invasive procedures in emerging Asian markets such as India ...
(Date:7/30/2014)... A formal complaint has been filed ... maker of the dialysis products GranuFlo and NaturaLyte. ... the state, its residents, physicians and dialysis clinics ... were recalled in 2012. There are hundreds of ... in the U.S. District Court, District of Massachusetts ...
(Date:7/30/2014)... University of So Paulo (USP) have identified an RNA ... the production of a protein, modulates the action of ... programmed cell death. , According to Sergio Verjovski-Almeida, ... a research funded by So Paulo Research Foundation (FAPESP), ... methods that are capable of stimulating the production of ...
Breaking Medicine News(10 mins):Health News:Older adults are at risk of financial abuse 2Health News:Hope for more accurate diagnosis of memory problems 2Health News:Global Catheters Market - Industry Size, Trends, Analysis, Growth, Players, Outlook and Forecast Research Report from 2014 to 2020: Grand View Research, Inc 2Health News:Global Catheters Market - Industry Size, Trends, Analysis, Growth, Players, Outlook and Forecast Research Report from 2014 to 2020: Grand View Research, Inc 3Health News:Louisiana Attorney General Files Complaint Against GranuFlo Manufacturer, Baron and Budd Reports 2Health News:Louisiana Attorney General Files Complaint Against GranuFlo Manufacturer, Baron and Budd Reports 3Health News:Brazilian researchers identify RNA that regulates cell death 2Health News:Brazilian researchers identify RNA that regulates cell death 3
... Schools Grant Applications Due June 17, HARRISBURG, ... statewide investment to help teach elementary students about,healthy ... Deputy,Agriculture Secretary Russell Redding today recognized a healthy ... Swain School in Allentown received a $15,000 Healthy ...
... may help cancer cells resist chemo, radiation , , TUESDAY, ... existing research suggests that cancer patients undergoing radiation or ... Although multivitamins may be all right in some cases, ... can spell trouble, said review author Dr. Brian Lawenda, ...
... Maker of Enzyte Restructures Organization, CINCINNATI, May 27 ... and seeing positive results.,Consumers are continuing to order their ... recent economic downturn, BPN has hired 70 employees in ... of their call center by the end,of ,08. Plans ...
... Discuss Successes and Challenges, SACRAMENTO, Calif., May ... experience an emotional or behavioral disorder every year ... A lack of knowledge,stigma, limited funding and inadequate ... children at risk for school failure,and dropping out, ...
... in baby,care than ever before. Whether you,re a mom who ... dad to whom the dear wife has delegated night,time feedings ... "diaper,dude":, The Moms on Call Guide to Basic Baby ... a guidebook for new dads that comes,with instructional DVD, answering ...
... 27, 2008 (BRONX, NY) The Albert Einstein ... a five-year grant of more than $8.5 million from ... will fund the Einstein-Montefiore Center for AIDS Research (CFAR) ... for the College, that together conduct some of the ...
Cached Medicine News:Health News:PA Agriculture Official Recognizes Healthy Garden at Lehigh County School 2Health News:Cancer Patients Should Steer Clear of Antioxidants 2Health News:Cancer Patients Should Steer Clear of Antioxidants 3Health News:Techno-Savvy Public Awareness Campaign Enables Families to Send a Powerful Message About Children's Mental Health 2Health News:Father's Day is Almost Here: Two Pediatric Nurses, Moms, Offer Practical Guidebook & DVD for New Dads 2Health News:Einstein-Montefiore Center for AIDS Research receives $8.5M award from NIH 2Health News:Einstein-Montefiore Center for AIDS Research receives $8.5M award from NIH 3
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Fenestrated 16 mm blades. Self-locking mechanism. Dull finish....
... Kawesch-Lancaster Lasik speculum has wide ... to provide clearance for the ... retract the lids and lashes ... the microkeratome. The blades are ...
Adjustable wire speculum with 17 mm open blades. Lid tension adjustable throughout procedure with thumb screw control. Angled 45 degrees....
Medicine Products: